A detailed history of Hilltop Holdings Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hilltop Holdings Inc. holds 9,368 shares of AZN stock, worth $621,098. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,368
Holding current value
$621,098
% of portfolio
0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $718,244 - $820,824
9,368 New
9,368 $729,000
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $324,113 - $387,573
-6,680 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$53.07 - $61.1 $111,553 - $128,432
2,102 Added 45.92%
6,680 $366,000
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $2,715 - $3,484
63 Added 1.4%
4,578 $243,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $147,645 - $200,546
-3,907 Reduced 46.39%
4,515 $202,000
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $109,334 - $129,934
-2,575 Reduced 23.42%
8,422 $420,000
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $6,900 - $7,820
-172 Reduced 1.54%
10,997 $490,000
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $132,977 - $148,672
-3,567 Reduced 24.21%
11,169 $460,000
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $122,830 - $148,892
-3,461 Reduced 19.02%
14,736 $596,000
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $228,163 - $256,823
-6,190 Reduced 25.38%
18,197 $691,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $380,204 - $434,457
-10,938 Reduced 30.96%
24,387 $965,000
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $85,891 - $92,106
-2,486 Reduced 6.57%
35,325 $1.24 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $20,606 - $22,893
625 Added 1.68%
37,811 $1.32 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $105,736 - $114,600
3,295 Added 9.72%
37,186 $1.29 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $981,483 - $1.15 Million
33,891
33,891 $1.15 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.